We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ACXP market cap is 14.77M. The company's latest EPS is USD -0.8630 and P/E is -1.01.
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |||
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -3.45M | -3.12M | -5.12M | -4.38M | -4.12M |
Net Income | -3.45M | -3.12M | -5.12M | -4.38M | -4.12M |
Year End 31 December 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 |
Operating Income | -12.81M | -12.09M | -14.58M |
Net Income | -12.75M | -12.09M | -14.58M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |||
Total Assets | 9.24M | 7.16M | 7.71M | 9.11M | 6.58M |
Total Liabilities | 3.02M | 3.22M | 3.04M | 3.11M | 3.15M |
Total Equity | 6.22M | 3.94M | 4.67M | 6M | 3.43M |
Year End 31 December 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 13.25M | 9.38M | 7.71M |
Total Liabilities | 844k | 2.06M | 3.04M |
Total Equity | 12.41M | 7.32M | 4.67M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |||
Operating | -3.51M | -5.6M | -9.8M | -3.06M | -5.94M |
Investing | N/A | N/A | N/A | N/A | N/A |
Financing | 3.54M | 3.54M | 8.16M | 4.51M | 4.83M |
Year End 31 December 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |
Operating | -5.01M | -7.54M | -9.8M |
Investing | N/A | N/A | N/A |
Financing | 14.8M | 3.7M | 8.16M |
Market Cap | 14.77M |
Price to Earnings Ratio | -1.01 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 1.97 |
Price to Book Ratio | 3.15 |
Dividend Yield | - |
Shares Outstanding | 16.89M |
Average Volume (1 week) | 126.63k |
Average Volume (1 Month) | 247.86k |
52 Week Change | -77.04% |
52 Week High | 5.28 |
52 Week Low | 0.72 |
Spread (Intraday) | 0.02 (2.22%) |
Company Name | Acurx Pharmaceuticals Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.acurxpharma.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions